Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.
CRyPTIC Consortium,;
2024
Nature communications, (2024).15 1 10.1038/s41467-023-44325-5.
Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials.
Natukunda, A; NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; Zziwa, C; Ninsiima, C; Tumusiime, J; Nyanzi, R; Namutebi, M; Kiwudhu, F; Van Dam, GJ; Corstjens, PL A M; Kizindo, R; Nkangi, R; Kabagenyi, J; Nassanga, B; Cose, S; WAJJA, A; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;
2024
The Lancet Global Health, (2024).12 11 10.1016/S2214-109X(24)00340-1.
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control.
WAJJA, A; Nassanga, B; NATUKUNDA, A; Serubanja, J; Tumusiime, J; Akurut, H; Oduru, G; Nassuuna, J; Kabagenyi, J; Morrison, H; Scott, H; Powell Doherty, R; Marshall, JL; Cabrera Puig, I; COSE, S; KALEEBU, P; WEBB, EL; Satti, I; McShane, H; ELLIOTT, AM; TB042 Study Team,;
2024
The Lancet. Infectious diseases, (2024).24 2 10.1016/s1473-3099(23)00758-2.
Estimating the impact of tuberculosis pathways on transmission - what is the gap left by passive case-finding?.
HORTON, KC; McCaffrey, T; RICHARDS, AS; SCHWALB, A; HOUBEN, RM G J;
2024
The Journal of infectious diseases (2024). 10.1093/infdis/jiae390.
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial.
NKURUNUNGI, G; Nassuuna, J; Natukunda, A; ZIRIMENYA, L; Walusimbi, B; Zziwa, C; Ninsiima, C; Kabagenyi, J; Kabuubi, PN; Van Dam, GJ; Corstjens, PL A M; Kayiwa, J; Kizza, M; Mutebe, A; Nakazibwe, E; Akello, FA; Sewankambo, M; Kiwanuka, S; Cose, S; WAJJA, A; KALEEBU, P; WEBB, EL; ELLIOTT, AM; POPVAC trial team,;
2024
The Lancet. Global health, (2024).12 11 10.1016/S2214-109X(24)00280-8.
Multi-platform whole genome sequencing for tuberculosis clinical and surveillance applications.
Thorpe, J; Sawaengdee, W; Ward, D; Campos, M; Wichukchinda, N; Chaiyasirinroje, B; Thanraka, A; Chumpol, J; PHELAN, JE; CAMPINO, S; Mahasirimongkol, S; CLARK, TG;
2024
Scientific reports, (2024).14 1 10.1038/s41598-024-55865-1.
Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
TADESSE, AW; Mganga, A; Dube, TN; Alacapa, J; Van Kalmthout, K; Letta, T; Mleoh, L; Garfin, AM C; Maraba, N; Charalambous, S; FOSTER, N; Jerene, D; FIELDING, KL;
2024
Frontiers in public health, (2024).12, 10.3389/fpubh.2024.1327971.
The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.
ZIRIMENYA, L; Natukunda, A; Nassuuna, J; NKURUNUNGI, G; Zziwa, C; Ninsiima, C; Kukundakwe, C; Nankabirwa, CM; Katushabe, C; Namusobya, LK; Oduru, G; Kabami, G; Kabali, J; Kayiwa, J; Kabagenyi, J; Van Dam, GJ; Corstjens, PL A M; Cose, S; WAJJA, A; Staedke, SG; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;
2024
The Lancet Global health, (2024).12 11 10.1016/S2214-109X(24)00281-X.
Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains.
PAINTER, H; WILLCOCKS, S; Zelmer, A; Reljic, R; Tanner, R; Fletcher, H;
2024
Tuberculosis (Edinburgh, Scotland), (2024).146, 10.1016/j.tube.2024.102494.
Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial.
Charalambous, S; Maraba, N; Jennings, L; Rabothata, I; Cogill, D; Mukora, R; Hippner, P; Naidoo, P; Xaba, N; Mchunu, L; Velen, K; Orrell, C; FIELDING, KL;
2024
EClinicalMedicine, (2024).75, 10.1016/j.eclinm.2024.102745.